Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 23

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Dealing with biofilms of Pseudomonas aeruginosa and Staphylococcus aureus: In vitro evaluation of a novel aerosol formulation of silver sulfadiazine

Moyano, Alejandro J., Mas, Carlos R., Colque, Claudia A., Smania, Andrea M. · 2020 · Burns

Abstract

The risk of infection of skin and soft tissue chronic wounds by gram-negative and gram-positive pathogens growing in biofilms is a major health-care concern. In this study we test a formulation of silver sulfadiazine, vitamin A and lidocaine (AF-SSD) for aerosol administration against biofilms of Pseudomonas aeruginosa and biofilms of methicillin-resistant (MRSA) and methicillin-sensitive (MSSA) strains of Staphylococcus aureus. The aerosol allows the administration of AF-SSD without the direct contact with the wound and avoids contamination of the product after reiterative usage. We evaluated in vitro the anti-biofilm activity of AF-SSD by carrying out different technical approaches such as resazurin assays to measure metabolic activity/viability, crystal violet staining assays to determine biofilm biomass, counting of CFUs and live/dead staining for confocal microscopy analysis. AF-SSD clearly affected biofilm viability, biomass and structure, in the three bacterial strains tested. AF-SSD displayed a strong anti-biofilm effect, showing total bactericidal activity on biofilms of P. aeruginosa at a 400-fold dilution of the product, and after a 100-fold and 10-fold dilution for MRSA and MSSA, respectively. Considering the benefits of aerosol administration, our results support this kind of formulation as a potential improvement over conventional treatments with silver sulfadiazine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.burns.2019.07.027

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 41

  1. Kennedy, 2010, Burns, biofilm and a new appraisal of burn wound sepsis, Burns, 36, 49, 10.1016/j.burns.2009.02.017 · DOI · Paper page
  2. Malone, 2017, The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data, J Wound Care, 26, 20, 10.12968/jowc.2017.26.1.20 · DOI · Paper page
  3. Omar, 2017, Microbial biofilms and chronic wounds, Microorganisms, 5, 9, 10.3390/microorganisms5010009 · DOI · Paper page
  4. Percival, 2012, A review of the scientific evidence for biofilms in wounds, Wound Repair Regen, 20, 647, 10.1111/j.1524-475X.2012.00836.x · DOI · Paper page
  5. Hall-Stoodley, 2004, Bacterial biofilms: from the natural environment to infectious diseases, Nat Rev Microbiol, 2, 95, 10.1038/nrmicro821 · DOI · Paper page
  6. Stoodley, 2002, Biofilms as complex differentiated communities, Annu Rev Microbiol, 56, 187, 10.1146/annurev.micro.56.012302.160705 · DOI · Paper page
  7. Costerton, 1995, Microbial biofilms, Annu Rev Microbiol, 49, 711, 10.1146/annurev.mi.49.100195.003431 · DOI · Paper page
  8. Bodey, 1983, Infections caused by Pseudomonas aeruginosa, Rev Infect Dis, 5, 279, 10.1093/clinids/5.2.279 · DOI · Paper page
  9. Chambers, 2009, Waves of resistance: Staphylococcus aureus in the antibiotic era, Nat Rev Microbiol, 7, 629, 10.1038/nrmicro2200 · DOI · Paper page
  10. El Zowalaty, 2015, Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies, Future Microbiol, 10, 1683, 10.2217/fmb.15.48 · DOI · Paper page
  11. Jarvis, 1992, Predominant pathogens in hospital infections, J Antimicrob Chemother, 29, 19, 10.1093/jac/29.suppl_A.19 · DOI · Paper page
  12. Schaberg, 1991, Major trends in the microbial etiology of nosocomial infection, Am J Med, 91, 10.1016/0002-9343(91)90346-Y · DOI · Paper page
  13. Moradali, 2017, Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence, Front Cell Infect Microbiol, 7, 39, 10.3389/fcimb.2017.00039 · DOI · Paper page
  14. Richardson, 2018, Gene exchange drives the ecological success of a multi-host bacterial pathogen, Nat Ecol Evol, 2, 1468, 10.1038/s41559-018-0617-0 · DOI · Paper page
  15. Skippington, 2011, Lateral genetic transfer and the construction of genetic exchange communities, FEMS Microbiol Rev, 35, 707, 10.1111/j.1574-6976.2010.00261.x · DOI
  16. Koo, 1989, Assessment of topical therapy of the burn wound with silver sulphadiazine after its use for 15 years in a burn unit, Burns, 15, 193, 10.1016/0305-4179(89)90182-4 · doi:10.1016/0305-4179(89)90182-4
  17. Marx, 2014, Silver in medicine: the basic science, Burns, 40, S9, 10.1016/j.burns.2014.09.010 · DOI
  18. Barillo, 2014, Silver in medicine: a brief history BC 335 to present, Burns, 40, S3, 10.1016/j.burns.2014.09.009 · DOI · Paper page
  19. Sibbald, 2017, Update: topical antimicrobial agents for chronic wounds, Adv Skin Wound Care, 30, 438, 10.1097/01.ASW.0000524471.28441.b9 · doi:10.1097/01.asw.0000524471.28441.b9
  20. Martínez, 2016, Linezolid as an eradication agent against assembled methicillin-resistant Staphylococcus aureus biofilms, RSC Adv, 6, 101023, 10.1039/C6RA19670E · doi:10.1039/c6ra19670e
  21. O’Toole, 1998, Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis, Mol Microbiol, 28, 449, 10.1046/j.1365-2958.1998.00797.x · DOI · Paper page
  22. Hudman, 2013, Resazurin-based assay for screening bacteria for radiation sensitivity, Springerplus, 2, 55, 10.1186/2193-1801-2-55 · DOI
  23. Sandberg, 2009, Pros and cons of using resazurin staining for quantification of viable Staphylococcus aureus biofilms in a screening assay, J Microbiol Methods, 78, 104, 10.1016/j.mimet.2009.04.014 · DOI
  24. Beaudoin, 2018, Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms, Sci Rep, 8, 14728, 10.1038/s41598-018-33016-7 · doi:10.1038/s41598-018-33016-7
  25. Toledo-Arana, 2005, Staphylococcus aureus develops an alternative, ica-independent biofilm in the absence of the arlRS two-component system, J Bacteriol, 187, 5318, 10.1128/JB.187.15.5318-5329.2005 · DOI · Paper page
  26. Kalan, 2017, Targeting biofilms of multidrug-resistant bacteria with silver oxynitrate, Int J Antimicrob Agents, 49, 719, 10.1016/j.ijantimicag.2017.01.019 · DOI
  27. Denny, 1978, A preliminary report on the spray application of topical silver sulfadiazine to burn wounds, J Trauma, 18, 730, 10.1097/00005373-197810000-00010 · doi:10.1097/00005373-197810000-00010
  28. Bjarnsholt, 2007, Silver against Pseudomonas aeruginosa biofilms, APMIS, 115, 921, 10.1111/j.1600-0463.2007.apm_646.x · DOI · Paper page
  29. Akiyama, 1998, Effects of sucrose and silver on Staphylococcus aureus biofilms, J Antimicrob Chemother, 42, 629, 10.1093/jac/42.5.629 · doi:10.1093/jac/42.5.629
  30. Schuenck, 2004, Oxacillin- and mupirocin-resistant Staphylococcus aureus: in vitro activity of silver sulphadiazine and cerium nitrate in hospital strains, J Chemother, 16, 453, 10.1179/joc.2004.16.5.453 · doi:10.1179/joc.2004.16.5.453
  31. Percival, 2019, Silver, biofilms and wounds: resistance revisited, Crit Rev Microbiol, 1
  32. Ranieri, 2018, Mechanisms of biofilm stimulation by subinhibitory concentrations of antimicrobials, Curr Opin Microbiol, 45, 164, 10.1016/j.mib.2018.07.006 · DOI
  33. Elliott, 2010, Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from cystic fibrosis patients, Antimicrob Agents Chemother, 54, 3024, 10.1128/AAC.00102-10 · doi:10.1128/aac.00102-10
  34. Hoffman, 2005, Aminoglycoside antibiotics induce bacterial biofilm formation, Nature, 436, 1171, 10.1038/nature03912 · DOI · Paper page
  35. Linares, 2006, Antibiotics as intermicrobial signaling agents instead of weapons, Proc Natl Acad Sci U S A, 103, 19484, 10.1073/pnas.0608949103 · DOI · Paper page
  36. Kaplan, 2012, Low levels of beta-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus, MBio, 3, 10.1128/mBio.00198-12 · DOI · Paper page
  37. Fu, 2007, Physiological role of retinyl palmitate in the skin, Vitam Horm, 75, 223, 10.1016/S0083-6729(06)75009-9 · DOI
  38. Hunt, 1986, Vitamin A and wound healing, J Am Acad Dermatol, 15, 817, 10.1016/S0190-9622(86)70238-7 · DOI · Paper page
  39. MacKay, 2003, Nutritional support for wound healing, Altern Med Rev, 8, 359
  40. Ong, 2018, Current anti-biofilm strategies and potential of antioxidants in biofilm control, Expert Rev Anti Infect Ther, 16, 855, 10.1080/14787210.2018.1535898 · DOI
  41. Boles, 2008, Endogenous oxidative stress produces diversity and adaptability in biofilm communities, Proc Natl Acad Sci U S A, 105, 12503, 10.1073/pnas.0801499105 · DOI · Paper page

Cited by

See all 23

Metadata

Authors
Moyano, A. J., Mas, C. R., Colque, C. A., & Smania, A. M.
Venue
Burns
Publisher
Elsevier BV
Published
2020-02
Volume
46
Issue
1
Pages
128-135
ISSN
0305-4179
Cited by
23
References
3
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.